메뉴 건너뛰기




Volumn 51, Issue 4, 2009, Pages 191-196

Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features

Author keywords

Chronic; Hepatitis C; Liver cirrhosis; Tissue inhibitor of metalloprotease 2

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; MMP2 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

EID: 77952362621     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (15)

References (43)
  • 2
    • 3543098600 scopus 로고    scopus 로고
    • Liver fibrosis: From the bench to clinical targets
    • DOI 10.1016/j.dld.2004.01.003
    • Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004;36:231-242 (Pubitemid 41115470)
    • (2004) Digestive and Liver Disease , vol.36 , Issue.4 , pp. 231-242
    • Pinzani, M.1    Rombouts, K.2
  • 6
    • 0030093706 scopus 로고    scopus 로고
    • Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation
    • Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70-76
    • (1996) Oral Dis , vol.2 , pp. 70-76
    • Reynolds, J.J.1
  • 7
    • 31744445961 scopus 로고    scopus 로고
    • Matrix metalloproteinases (MMPs) in health and disease: An overview
    • Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006;11:1696-1701
    • (2006) Front Biosci , vol.11 , pp. 1696-1701
    • Malemud, C.J.1
  • 8
    • 0033618337 scopus 로고    scopus 로고
    • Waessner JE Matrix metalloproteinases
    • Nagase H, Waessner JE Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494
    • (1999) J Biol Chem , vol.274 , pp. 21491-21494
    • Nagase, H.1
  • 9
    • 0037693895 scopus 로고    scopus 로고
    • Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry
    • Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 2003;92:827-839
    • (2003) Circ Res , vol.92 , pp. 827-839
    • Visse, R.1    Nagase, H.2
  • 10
    • 31344458952 scopus 로고    scopus 로고
    • Structure and function of matrix metalloproteinases and TIMPs
    • DOI 10.1016/j.cardiores.2005.12.002, PII S0008636305005651
    • Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573 (Pubitemid 43139720)
    • (2006) Cardiovascular Research , vol.69 , Issue.3 , pp. 562-573
    • Nagase, H.1    Visse, R.2    Murphy, G.3
  • 11
    • 20644465610 scopus 로고    scopus 로고
    • Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation
    • DOI 10.1002/hep.510300431
    • Benyon RC, Hovell CJ, Da Gaca M, Jones EH, Iredale JP, Arthur MJ. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 1999;30:977-986 (Pubitemid 29458287)
    • (1999) Hepatology , vol.30 , Issue.4 , pp. 977-986
    • Benyon, R.C.1    Hovell, C.J.2    Da Gaca, M.3    Jones, E.H.4    Iredale, J.P.5    Arthur, M.J.6
  • 12
    • 0032952079 scopus 로고    scopus 로고
    • Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-α and TGF-β1
    • DOI 10.1016/S0168-8278(99)80007-5
    • Knittel T, Mehde M, Kobold D, Saile B, Dimer C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-betal. J Hepatol 1999;30:48-60. (Pubitemid 29023652)
    • (1999) Journal of Hepatology , vol.30 , Issue.1 , pp. 48-60
    • Knittel, T.1    Mehde, M.2    Kobold, D.3    Saile, B.4    Dinter, C.5    Ramadori, G.6
  • 13
    • 0030030039 scopus 로고    scopus 로고
    • Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
    • DOI 10.1053/gast.1996.v110.pm8608892
    • Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110:821-831 (Pubitemid 26071850)
    • (1996) Gastroenterology , vol.110 , Issue.3 , pp. 821-831
    • Benyon, R.C.1    Iredale, J.P.2    Goddard, S.3    Winwood, P.J.4    Arthur, M.J.5
  • 14
    • 0031740778 scopus 로고    scopus 로고
    • Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
    • Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CC et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 1998;153:1895-1902
    • (1998) Am J Pathol , vol.153 , pp. 1895-1902
    • Kossakowska, A.E.1    Edwards, D.R.2    Lee, S.S.3    Urbanski, L.S.4    Stabbler, A.L.5    Zhang, C.C.6
  • 15
    • 0034856294 scopus 로고    scopus 로고
    • Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
    • Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430
    • (2001) J Hepatol , vol.35 , pp. 421-430
    • Bruix, J.1    Sherman, M.2    Llovet, J.M.3    Beaugrand, M.4    Lencioni, R.5    Burroughs, A.K.6
  • 16
    • 1242307263 scopus 로고    scopus 로고
    • The Barcelona approach: Diagnosis, staging and treatment of hepatocellular carcinoma
    • Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging and treatment of hepatocellular carcinoma. Liver Transpl 2004;10:S115-120.
    • (2004) Liver Transpl , vol.10
    • Llovet, J.M.1    Fuster, J.2    Bruix, J.3
  • 17
    • 57349187662 scopus 로고    scopus 로고
    • A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma
    • Bertino G, Ardiri AM, Boemi PM, lerna D, Interlandi D, Caruso L et al. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma. Panminerva Med 2008;50:221 6.
    • (2008) Panminerva Med , vol.50 , Issue.221 , pp. 6
    • Bertino, G.1    Ardiri, A.M.2    Boemi, P.M.3    Lerna, D.4    Interlandi, D.5    Caruso, L.6
  • 18
    • 0033557988 scopus 로고    scopus 로고
    • Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
    • Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K et al. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999;85:8128.
    • (1999) Cancer , vol.85 , pp. 8128
    • Okuda, H.1    Nakanishi, T.2    Takatsu, K.3    Saito, A.4    Hayashi, N.5    Watanabe, K.6
  • 19
    • 0033048769 scopus 로고    scopus 로고
    • Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma
    • DOI 10.1016/S0002-9270(98)00811-9, PII S0002927098008119
    • Nomura F, Ishijima M, Kuwa K, Tanaka N, Nakai T, Ohnishi K. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. Am J Gastroenterol 1999;94:650-654 (Pubitemid 29124861)
    • (1999) American Journal of Gastroenterology , vol.94 , Issue.3 , pp. 650-654
    • Nomura, F.1    Ishijima, M.2    Kuwa, K.3    Tanaka, N.4    Nakai, T.5    Ohnishi, K.6
  • 21
    • 0022647490 scopus 로고
    • Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
    • Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-173 (Pubitemid 16125908)
    • (1986) Journal of Hepatology , vol.2 , Issue.2 , pp. 165-173
    • Piccinino, F.1    Sagnelli, E.2    Pasquale, G.3
  • 22
    • 0037809517 scopus 로고    scopus 로고
    • Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection
    • DOI 10.1080/00365520310000825
    • Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003;38:427-432 (Pubitemid 36606313)
    • (2003) Scandinavian Journal of Gastroenterology , vol.38 , Issue.4 , pp. 427-432
    • Siddique, I.1    El-Naga, H.A.2    Madda, J.P.3    Memon, A.4    Hasan, F.5
  • 23
    • 33846846344 scopus 로고    scopus 로고
    • Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B
    • Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:52531.
    • (2007) World J Gastroenterol , vol.13 , pp. 52531
    • Sebastiani, G.1    Vario, A.2    Guido, M.3    Alberti, A.4
  • 24
    • 44849126116 scopus 로고    scopus 로고
    • Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma
    • Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Inter Med 2008;47:569-575
    • (2008) Inter Med , vol.47 , pp. 569-575
    • Lin, C.S.1    Chang, C.S.2    Yang, S.S.3    Yeh, H.Z.4    Lin, C.W.5
  • 25
    • 33644901827 scopus 로고    scopus 로고
    • Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
    • Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:68693.
    • (2006) J Hepatol , vol.44 , pp. 68693
    • Sebastiani, G.1    Vario, A.2    Guido, M.3    Noventa, F.4    Plebani, M.5    Pistis, R.6
  • 26
    • 0042265556 scopus 로고    scopus 로고
    • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
    • Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526
    • (2003) Hepatology , vol.38 , pp. 518-526
    • Wai, C.T.1    Greenson, J.K.2    Fontana, R.J.3    Kalbfleisch, J.D.4    Marrero, J.A.5    Conjeevaram, H.S.6
  • 27
    • 63549099586 scopus 로고    scopus 로고
    • Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis
    • Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009;16:300-314
    • (2009) J Viral Hepat , vol.16 , pp. 300-314
    • Castera, L.1
  • 29
    • 58149461835 scopus 로고    scopus 로고
    • Interpreting liver stiffnes in the cirrhotic range: What are we measuring?
    • Castera L, Foras X, Alberti A. Interpreting liver stiffnes in the cirrhotic range: what are we measuring? J Hepatol 2009;50:424-425
    • (2009) J Hepatol , vol.50 , pp. 424-425
    • Castera, L.1    Foras, X.2    Alberti, A.3
  • 30
    • 0030724689 scopus 로고    scopus 로고
    • Dual expression of matrix metalloproteinase-2 and membrane-type 1- Matrix metalloproteinase in fibrotic human livers
    • Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1matrix metalloproteinase in fibrotic human livers. Hepatology 1997;26:1521-1529 (Pubitemid 27520018)
    • (1997) Hepatology , vol.26 , Issue.6 , pp. 1521-1529
    • Takahara, T.1    Furui, K.2    Yata, Y.3    Jin, B.4    Zhang, L.P.5    Nambu, S.6    Sato, H.7    Seiki, M.8    Watanabe, A.9
  • 31
    • 0028906431 scopus 로고
    • Increased expression of matrix metalloproteinase-fl in experimental liver fibrosis in rats
    • Takahara T, Furui K, Funaki J, Nakayania Y, Itoh H, Miyabayashi C et al. Increased expression of matrix metalloproteinase-fl in experimental liver fibrosis in rats. Hepatology 1995;21:787-795
    • (1995) Hepatology , vol.21 , pp. 787-795
    • Takahara, T.1    Furui, K.2    Funaki, J.3    Nakayania, Y.4    Itoh, H.5    Miyabayashi, C.6
  • 32
  • 33
    • 1442301501 scopus 로고    scopus 로고
    • Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-I and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and hyaluronic acid
    • Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-I and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004;99:271-279
    • (2004) Am J Gastroenterol , vol.99 , pp. 271-279
    • Leroy, V.1    Monier, F.2    Bottari, S.3    Trocme, C.4    Sturm, N.5    Hilleret, M.N.6
  • 34
    • 0033020765 scopus 로고    scopus 로고
    • Plasma levels of matrix metalloproteinase-2 (MMP2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-I and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: Comparison using ROC analysis
    • Walsh KM, Timms P, Campbell S, MacSween RN, Morris AJ. Plasma levels of matrix metalloproteinase-2 (MMP2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-I and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis. Dig Dis Sei 1999;44:624-630
    • (1999) Dig Dis Sei , vol.44 , pp. 624-630
    • Walsh, K.M.1    Timms, P.2    Campbell, S.3    MacSween, R.N.4    Morris, A.J.5
  • 35
    • 0035119323 scopus 로고    scopus 로고
    • Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C
    • Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Flemming P. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J Hepatol 2001;34:239-247
    • (2001) J Hepatol , vol.34 , pp. 239-247
    • Lichtinghagen, R.1    Michels, D.2    Haberkorn, C.I.3    Arndt, B.4    Bahr, M.5    Flemming, P.6
  • 36
    • 0036135242 scopus 로고    scopus 로고
    • Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C
    • DOI 10.1016/S0009-8981(01)00730-6, PII S0009898101007306
    • Boeker KH, Habenkorn CI, Michels D, Flemming P, Manns MP, Lichtinghagen R. Diagnostic potential of circulating TIMP-I and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta 2002;316:71-81. (Pubitemid 34028190)
    • (2002) Clinica Chimica Acta , vol.316 , Issue.1-2 , pp. 71-81
    • Boeker, K.H.1    Haberkorn, C.I.2    Michels, D.3    Flemming, P.4    Manns, M.P.5    Lichtinghagen, R.6
  • 37
    • 33846846344 scopus 로고    scopus 로고
    • Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B
    • Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:52531.
    • (2007) World J Gastroenterol , vol.13 , pp. 52531
    • Sebastiani, G.1    Vario, A.2    Guido, M.3    Alberti, A.4
  • 38
    • 44849126116 scopus 로고    scopus 로고
    • Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma
    • Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Inter Med 2008;47:569-575
    • (2008) Inter Med , vol.47 , pp. 569-575
    • Lin, C.S.1    Chang, C.S.2    Yang, S.S.3    Yeh, H.Z.4    Lin, C.W.5
  • 39
    • 0035082529 scopus 로고    scopus 로고
    • Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes
    • Callejas NA, Casado M, Diaz-Guerra MJ, Boscà L, Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 2001;33:86086.
    • (2001) Hepatology , vol.33 , pp. 86086
    • Callejas, N.A.1    Casado, M.2    Diaz-Guerra, M.J.3    Boscà, L.4    Martin-Sanz, P.5
  • 40
    • 0031454180 scopus 로고    scopus 로고
    • Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with fiver disease
    • Ebata M, Fukuda Y, Nakano I, Katano Y, Fujimoto N, Hayakawa T. Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with fiver disease. Liver 1997;17:293-299
    • (1997) Liver , vol.17 , pp. 293-299
    • Ebata, M.1    Fukuda, Y.2    Nakano, I.3    Katano, Y.4    Fujimoto, N.5    Hayakawa, T.6
  • 41
    • 0031048395 scopus 로고    scopus 로고
    • Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C
    • Relationship to interferon response.
    • Kasahara A, Hayashi N, Mochizuki K, Oshita M, Katayama K, Kato M et al. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response. J Hepatol 1997;26:574-583
    • (1997) J Hepatol , vol.26 , pp. 574-583
    • Kasahara, A.1    Hayashi, N.2    Mochizuki, K.3    Oshita, M.4    Katayama, K.5    Kato, M.6
  • 42
    • 0034934457 scopus 로고    scopus 로고
    • Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C
    • DOI 10.1007/s005350170084
    • Murawaki Y, Bcuta Y, OkamotoK, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001;36:399-406. (Pubitemid 32633448)
    • (2001) Journal of Gastroenterology , vol.36 , Issue.6 , pp. 399-406
    • Murawaki, Y.1    Ikuta, Y.2    Okamoto, K.3    Koda, M.4    Kawasaki, H.5
  • 43
    • 0033968058 scopus 로고    scopus 로고
    • Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C
    • Lichtinghagen R, Huegel O, Seifert T, Haberkorn CI, Michels D, Flemming P et al Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 2000;46:183-192
    • (2000) Clin Chem , vol.46 , pp. 183-192
    • Lichtinghagen, R.1    Huegel, O.2    Seifert, T.3    Haberkorn, C.I.4    Michels, D.5    Flemming, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.